Qualigen Therapeutics Inc (QLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | QLGN | CANF | XBIO | ||
| Company | Qualigen Therapeutics Inc | Can-Fite Biopharma Ltd ADR | Xenetic Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 2.98 | 4.45 | 2.20 | ||
| High | 3.34 | 4.65 | 2.25 | ||
| Low | 2.86 | 4.29 | 2.20 | ||
| Latest | 3.21 | 4.65 | 2.25 | ||
| Change | +0.17 | +0.21 | -0.03 | ||
| % Change | +5.59% | +4.73% | -1.32% | ||
| Volume | 373,800 | 31,200 | 3,000 | ||
| 20-Day Average Volume | 3,514,640 | 55,220 | 24,195 | ||
| Previous Close | 3.04 | 4.44 | 2.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.87 | 4.30 | 2.28 | ||
| 20-Day Raw Stochastic | 23.75% | 87.84% | 27.03% | ||
| 20-Day Relative Strength | 50.58 | 50.08 | 48.04 | ||
| Weighted Alpha | -59.50 | -83.89 | -59.53 | ||
| Today's Opinion | 24% Sell | 56% Sell | 88% Sell | ||
| Previous Opinion | 24% Sell | 80% Sell | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.52% since 11/11/25 | +7.64% since 02/12/26 | -5.86% since 02/12/26 | ||
| Low | 2.36 on 11/13/25 | 4.12 on 02/13/26 | 2.16 on 02/17/26 | ||
| High | 3.34 on 11/18/25 | 4.65 on 02/20/26 | 2.46 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -11.81% since 10/17/25 | +16.54% since 01/20/26 | -10.00% since 01/20/26 | ||
| Low | 2.35 on 11/07/25 | 3.91 on 01/21/26 | 2.05 on 02/09/26 | ||
| High | 5.97 on 10/24/25 | 4.74 on 02/10/26 | 2.79 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +68.95% since 08/18/25 | -24.51% since 11/20/25 | -2.60% since 11/20/25 | ||
| Low | 1.66 on 09/04/25 | 3.36 on 12/29/25 | 1.90 on 12/16/25 | ||
| High | 8.81 on 09/22/25 | 7.90 on 12/01/25 | 2.79 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | -17.05% since 05/16/25 | -64.60% since 08/20/25 | -19.35% since 08/20/25 | ||
| Low | 1.61 on 08/13/25 | 3.36 on 12/29/25 | 1.90 on 12/16/25 | ||
| High | 8.81 on 09/22/25 | 13.60 on 08/21/25 | 13.93 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,442 | 5,813 | 5,224 | ||
| Shares Outstanding, K | 1,695 | 1,309 | 2,291 | ||
| Annual Sales | 0 | 670,000 | 2,500,000 | ||
| Annual Net Income | -6,260,000 | -7,880,000 | -3,960,000 | ||
| Last Quarter Sales | 0 | 160,000 | 1,030,000 | ||
| Last Quarter Net Income | -2,040,000 | -1,650,000 | -510,000 | ||
| 60-Month Beta | 0.24 | 1.07 | 2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -4.68 on 11/14/25 | N/A | -0.33 on 11/12/25 | ||
| Latest Earnings Date | 06/29/26 | 04/13/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||